Related Experiment Video
Updated: Mar 2, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1.
C Gareri1, C Iaconetti2, S Sorrentino2
1Division of Cardiology, Department of Medical and Surgical Science, "Magna Graecia" University, Viale Europa, Catanzaro 88100, Italy; Department of Medicine, Duke University, Durham, 27710, NC, USA.
MicroRNA 125a-5p (miR-125a-5p) regulates vascular smooth muscle cells (VSMCs) and may prevent in-stent restenosis. Overexpressing miR-125a-5p reduces VSMC proliferation and migration, suggesting therapeutic potential.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Cell Biology
Background:
- MicroRNAs regulate vascular smooth muscle cells (VSMCs) and their phenotypic switch.
- VSMC phenotypic switch is critical in bare metal in-stent restenosis after percutaneous coronary intervention.
- The specific role of miR-125a-5p in VSMCs remains largely unknown.
Purpose of the Study:
- To investigate the role of miR-125a-5p in regulating VSMC phenotypic switch.
- To determine if miR-125a-5p influences VSMC proliferation, migration, and differentiation markers.
- To identify the molecular targets of miR-125a-5p in VSMCs.
Main Methods:
- In vivo studies of miR-125a-5p expression after vascular injury.
- Overexpression of miR-125a-5p in VSMCs to assess its functional effects.
- Analysis of VSMC proliferation, migration, and expression of VSMC-specific markers.
- Identification of direct targets of miR-125a-5p using molecular assays.
Main Results:
- miR-125a-5p is highly expressed in VSMCs but down-regulated following vascular injury.
- Overexpression of miR-125a-5p significantly reduced VSMC proliferation and migration.
- miR-125a-5p promoted the expression of VSMC differentiation markers (alpha smooth muscle actin, myosin heavy chain 11, smooth muscle 22 alpha).
- miR-125a-5p directly targets ETS-1, a key regulator of the PDGF-BB pathway in VSMCs.
Conclusions:
- miR-125a-5p acts as a negative regulator of VSMC proliferation and migration.
- miR-125a-5p promotes VSMC differentiation by targeting ETS-1 and inhibiting the PDGF-BB pathway.
- miR-125a-5p is a potential therapeutic target for preventing in-stent restenosis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Master Transcription Regulators
Mechanism of Angiogenesis

